ASTH Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$49.33median target· current $35.56 (+38.7%)11 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio58.30Forward 23.04
EPS (TTM)$0.61110.1% YoY
Profit margin0.9%HEALTHCARE
Market cap$1.76BSmall cap
Valuation
- Forward P/E
- 23.04
- PEG ratio
- 0.00
- P/B
- 2.20
- P/S (TTM)
- 0.50
- EV/EBITDA
- 14.42
Profitability & growth
- ROE (TTM)
- 5.7%
- Operating margin
- 3.0%
- Revenue growth YoY
- 55.6%
- Dividend yield
- —
- Beta
- 0.89
Last earnings
May 7, 2026 · Estimate $0.65 · Reported $0.74
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Astrana Health Inc
Company profileAstrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. The company is headquartered in Alhambra, California.
Classification
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 1668 S. GARFIELD AVENUE, ALHAMBRA, CA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$1.76B
Shares outstanding$49.6M
52W high$51.60
52W low$18.08
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent